Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2011 Nov 1.
Published in final edited form as: FEMS Immunol Med Microbiol. 2010 Nov;60(2):186–189. doi: 10.1111/j.1574-695X.2010.00730.x

Detection of the CS20 colonization factor antigen in diffuse-adhering E. coli strains

Theresa J Ochoa 1,2,*, Fulton P Rivera 1, Maria Bernal 3, Rina Meza 3, Lucie Ecker 4, Ana I Gil 4, David Cepeda 3, Susan Mosquito 1, Erik Mercado 1, Ryan C Maves 3, Eric R Hall 5, Ann-Mari Svennerholm 6, Annette McVeigh 5, Stephen Savarino 5, Claudio F Lanata 4,7
PMCID: PMC3170001  NIHMSID: NIHMS229007  PMID: 21064230

Abstract

We analyzed a randomly-selected group of 30 diffusely adherent (DAEC), 30 enteropathogenic, 30 enteroaggregative, and 5 shiga toxin-producing E. coli strains isolated from children with diarrhea. Enterotoxigenic E. coli (ETEC) colonization factors (CFs) were evaluated by dot-blot assay using 21 CF-specific monoclonal antibodies. Out of 95 non-ETEC strains, three DAEC were found to express CS20. No other E. coli expressed CFs. We confirmed the 3 CS20-positive strains as ETEC-negative by repeat PCR and as toxin-negative by GM1-ELISA. To our knowledge, this is the first study that has identified currently-recognized CFs in non-ETEC diarrheagenic E. coli strains identified by molecular methods. CFs may be an unrecognized relevant adherence factor in other E. coli, which may then play a role in pathogenesis and the immune response of the host.

Keywords: colonization factors, colonization factor antigens, enterotoxigenic E. coli, diarrheagenic E. coli, diffusely adherent E. coli, diarrhea, children


Enterotoxigenic Escherichia coli (ETEC) is one of the main causes of pediatric diarrhea in developing countries and in travelers´ diarrhea. The main virulence factors of ETEC are the heat-stable (ST) and heat-labile (LT) enterotoxins, and the colonization factor antigens (CFs or CFAs) (Qadri et al., 2005; Walker et al., 2007; Svennerholm & Tobias, 2008). CFs are antigenic fimbriae that enable bacteria to adhere to and colonize host intestinal mucosa. The 25 CFs characterized in ETEC (Walker et al., 2007) have been infrequently described in other diarrheagenic E. coli. The aim of this study was to determine the presence of CFs in non-ETEC diarrheagenic E. coli strains.

We analyzed a randomly-selected group of 30 out of 36 diffusely-adherent E. coli (DAEC), 30 out of 56 enteropathogenic E. coli (EPEC), 30 out of 111 enteroaggregative E. coli (EAEC) and 5 out of 5 Shiga toxin-producing E. coli (STEC) previously isolated during a passive surveillance diarrhea study of 1034 children under 12 months of age in Lima, Peru (Ochoa et al., 2009). For sampling, we prepared a list of all positive strains by category, assigned them a correlative number, and performed a selection of random numbers using Microsoft Excel (simple random sampling). In the case of STEC, we included all five of the isolated strains, due to the low number of isolates. Five E. coli colonies per patient were analyzed by a multiplex real-time PCR method using previously validated specific primers for each pathotype: EAEC (aggR), ETEC (lt, st), EPEC (eaeA), STEC (stx1, stx2), DAEC (daaD), and enteroinvasive E. coli (EIEC) (ipaH) (Guion et al., 2008).

Two colonies from each strain were tested for CFs by a dot-blot assay using 21 monoclonal antibodies: CFA/I, CS1-CS7, CS8 (CFA/III), CS12 (PCF0159), CS14 (PCF0166), CS17, CS18, CS20, CS19, PCF039 (P19A6), PCF071 (P8C1), Ag150 (P1F2), Fim4264 (P3H5), Fim4089 (P5H10) and Fim7162 (P7H5), as previously described (Lopez-Vidal et al., 1990; Viboud et al., 1993; Sjoling et al., 2007). The monoclonal antibodies were provided by Dr. A.-M. Svennerholm (University of Gothenburg, Sweden) and Drs. S. Farid and H. Shaheen (NAMRU-3, Cairo, Egypt). CF positive strains were confirmed to lack ETEC-associated toxins by repeat PCR (lt and/or st genes) (Guion et al., 2008) and by a ganglioside-GM1-ELISA (LT) and inhibition GM1-ELISA (ST) (Svennerholm & Wiklund, 1983; Svennerholm et al., 1986; Sjöling et al., 2007). Serotyping was performed for somatic (O) and flagellar (H) antigens using an E. coli antisera kit (Denka Seiken, Tokyo, Japan).

Three CF+ strains were identified in 95 non-ETEC strains (3%). All CFs were coli surface antigen 20 (CS20); the 3 strains were all DAEC (3 of 30 DAEC, 10%). All other E. coli were negative for CFs. Presence of CS20 was significantly more frequent in DAEC than in other non-ETEC diarrheagenic E. coli (10% vs. 0%, p<0.05). Repeat PCR for lt and st, the genes encoding for the ETEC-associated toxins LT and ST was negative, as was a GM1-ELISA specific for LT and ST themselves. All of the CS20-positive DAEC strains showed a diffuse adherence pattern in the HEp-2 cell assay, similar to the other 28 DAEC clinical isolates analyzed in our laboratory. All three CS20-positive DAEC strains were non-typeable by O/H serotyping, which was performed twice using a commercial E. coli antisera kit (Denka Seiken, Tokyo). The CS20-positive DAEC strains were from acute diarrheal episodes (mean duration 7 days) in children with a mean age of 4 months. DAEC were the only pathogens isolated from each of these three episodes of illness.

In order to characterize the CS20 positive DAEC strains, we first attempted to demonstrate the transferability of a putative CS20-encoding plasmid to other E. coli strains. These conjugal transfer experiments were carried out using E. coli J53-2 (pro, met, RifR) as the recipient strain, as previously described (Soufi et al., 2009). Briefly, overnight cultures of donor and recipient strains were grown in Mueller-Hinton broth at 37° C. These strains were then mixed in a 1:10 proportion and incubated at 37° C for an additional 4 hours. 0.1mL of the resulting mixture was spread onto Mueller-Hinton agar plates containing rifampin (150mg/L) plus streptomycin (50mg/L). Plates were again incubated at 37° C for 48 hours. Rifampin-resistant transconjugants growing on the selection medium were recovered and subjected to antibiotic susceptibility testing and the dot-blot assay using the CS20 monoclonal antibody to confirm the possible acquisition of plasmid-related genes. Transfer of the resistant phenotype was successful as demonstrated by the presence of novel drug resistance in the transconjugant strain by routine disk-diffusion methods, but we were unable to detect evidence of CS20-like fimbriae by dot-blot assay in the recipient strains. The CS20-positive DAEC strains were further characterized in Dr. Savarino´s laboratory at the Enteric Diseases Department at the Naval Medical Research Center, Silver Spring, Maryland, USA. PCR and sequencing of the whole cell lysates and of the isolated plasmid preparations were performed using primers for the csnA gene, which encodes the major CS20 subunit (CS20-F: CCTTTGCCAGGTAAAAACAGATG and CS20-R: ACGAATGGTCAAAACACCAGTTG) (Puiprom et al., 2009). The strain WS7179A (a CS20-positive sequenced strain) was used as the positive control. Testing of both the whole cell lysates and isolated plasmid preparations were negative in the DAEC strains, however. The reason for this is unclear. We hypothesize that the CS20-like fimbria detected by dot-blot assay in these three DAEC strains may not be encoded by a transferable plasmid, as is the case in wild-type ETEC, and may thus be chromosomal. Additionally, the gene encoding this CS20-like molecule may not appear to be directly homologous to csnA and thus would not be detected by primers specific for that gene.

Many pathogenic bacteria have the ability to adhere to specific host tissues to colonize. Bacterial adherence is mediated in part by polymeric adhesive fibers termed “pili” or “fimbriae” that facilitate the initial attachment to epithelial cells and subsequent colonization of the host. The CFs are prominent examples of these structures and are most often designated by number as coli surface antigens, with the exception of CFA/I and certain others. These virulence determinants mediate bacterial adherence to intestinal mucosa. Studies of ETEC strains have shown that the most common CFs are CFA/I and combinations of CS1- CS6 (Qadri et al., 2005). Protective immunity to CFs may occur following multiple natural infections, leading many investigators to believe that vaccines against ETEC infections should contain the immunogenic B subunit of the LT and a combination of the most common CFs (Qadri et al., 2005; Walker et al., 2007; Svennerholm & Tobias, 2008). The gene encoding the major subunit of CS20, csnA, is located on a plasmid and shows a high degree of affinity to the major fimbrial subunits of CS12 and CS18, as well as to F6 (also referred to as 987P), a CS from a porcine ETEC strain (Valvatne et al., 1996; Valvatne et al., 2004).

In this study, we found evidence of 3 DAEC strains expressing CS20-like molecules. DAEC strains are identified on the basis of their diffuse adherence pattern on cultured epithelial cells. One of the adherence factors of DAEC is the surface fimbria (designated F1845) that is responsible for the diffuse adherence phenotype in a prototype strain. These fimbriae are homologous with members of the Afa/Dr family of adhesins (Le Bouguénec & Servin, 2006), which are identified by hybridization to a specific probe, daaC, common to operons encoding Afa/Dr adhesions.

To our knowledge, this is the first study that has searched for most currently recognized CFs in non-ETEC diarrheagenic E. coli strains identified by molecular methods. Earlier studies have looked at CFA/I and CFA/II in non-ETEC E. coli strains identified by serology, with variable results (Cravioto et al., 1982; Iyer et al., 1983; Caron et al., 1990).

The presence of CFs in other diarrheagenic E. coli has multiple potential implications. CFs may be an unrecognized relevant adherence factor in other E. coli, which may then play a role in pathogenesis and the immune response of the host. Candidate vaccines for ETEC based upon common CFs and the B subunit of LT could potentially protect against other enteric pathogens expressing CFs. Further studies are needed to evaluate the presence of CFs or CF-like molecules in a larger number of pathogenic E. coli.

Supplementary Material

Supp Fig S1

Acknowledgements

Dr. T. Ochoa is supported by 1K01TW007405. This work has been partially funded by Dr. C. Lanata´s Institutional Research Funds and by the United States Military Infectious Disease Research Program (MIDRP), work unit number 60000.000.0.B0017.

We will like to thank Dr. Sami Farid Khalil and Dr. Hind Shaheen of the Naval Medical Research Unit THREE (Cairo, Egypt) for providing the monoclonal antibodies and for their technical assistance.

The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Department of the Navy, Department of Defense, the U.S. Government, nor that of the National Institutes of Health and other funding institutions. This study protocol was approved by the Naval Medical Research Center Detachment Institutional Review Board in compliance with all applicable Federal regulations governing the protection of human subjects.

M. Bernal, R. Meza, D. Cepeda, E. Hall, R. Maves, A. McVeigh and S. Savarino are employees of the U.S. Government. This work was prepared as part of their official duties. Title 17 U.S.C. §105 provides that ‘Copyright protection under this title is not available for any work of the United States Government.’ Title 17 U.S.C. §101 defines a U.S. Government work as a work prepared by a military service member or employee of the U.S. Government as part of that person’s official duties.

References

  • 1.Caron J, Maneval DR, Kaper JB, Scott JR. Association of rns homologs with colonization factor antigens in clinical Escherichia coli isolates. Infect Immun. 1990;58:3442–3444. doi: 10.1128/iai.58.10.3442-3444.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Cravioto A, Scotland SM, Rowe B. Hemagglutination activity and colonization factor antigens I and II in enterotoxigenic and non-enterotoxigenic strains of Escherichia coli isolated from humans. Infect Immun. 1982;36:189–197. doi: 10.1128/iai.36.1.189-197.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Guion CE, Ochoa TJ, Walker CM, Barletta F, Cleary TG. Detection of diarrheagenic Escherichia coli by use of melting-curve analysis and real-time multiplex PCR. J Clin Microbiol. 2008;46:1752–1757. doi: 10.1128/JCM.02341-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Iyer L, Deshpande CK, Kale VV, Jain MK. Correlation between serotypes, enterotoxin production and presence of colonisation factor antigens (CFA) in E. coli isolates from acute diarrhoea in children. J Postgrad Med. 1983;29:62–66. [PubMed] [Google Scholar]
  • 5.Le Bouguénec C, Servin AL. Diffusely adherent Escherichia coli strains expressing Afa/Dr adhesins (Afa/Dr DAEC): hitherto unrecognized pathogens. FEMS Microbiol Lett. 2006;256:185–194. doi: 10.1111/j.1574-6968.2006.00144.x. [DOI] [PubMed] [Google Scholar]
  • 6.López-Vidal Y, Calva JJ, Trujillo A, Ponce de León A, Ramos A, Svennerholm AM, Ruiz-Palacios GM. Enterotoxins and adhesins of enterotoxigenic Escherichia coli: are they risk factors for acute diarrhea in the community? J Infect Dis. 1990;162:442–447. doi: 10.1093/infdis/162.2.442. [DOI] [PubMed] [Google Scholar]
  • 7.Ochoa TJ, Ecker L, Barletta F, Mispireta M, Gil AI, Contreras C, Molina M, Amemiya I, Verastegui H, Hall ER, Cleary TG, Lanata CF. Age-related susceptibility to infection with diarrheagenic E. coli in infants from peri-urban areas of Lima, Peru. Clin Infect Dis. 2009;49:1694–1702. doi: 10.1086/648069. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Puiprom O, Chantaroj S, Gangnonngiw W, Okada K, Honda T, Taniguchi T, Sawanpanyalert P. Identification of colonization factors of enterotoxigenic Escherichia coli with PCR-based technique. Epidemiol Infect. 2010;138:519–524. doi: 10.1017/S0950268809990720. [DOI] [PubMed] [Google Scholar]
  • 9.Qadri F, Svennerholm AM, Faruque AS, Sack RB. Enterotoxigenic Escherichia coli in developing countries: epidemiology, microbiology, clinical features, treatment, and prevention. Clin Microbiol Rev. 2005;18:465–483. doi: 10.1128/CMR.18.3.465-483.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Sjöling A, Wiklund G, Savarino SJ, Cohen DI, Svennerholm AM. Comparative analyses of phenotypic and genotypic methods for detection of enterotoxigenic Escherichia coli toxins and colonization factors. J Clin Microbiol. 2007;45:3295–3301. doi: 10.1128/JCM.00471-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Soufi L, Abbassi MS, Sáenz Y, Vinué L, Somalo S, Zarazaga M, Abbas A, Dbaya R, Khanfir L, Ben Hassen A, Hammami S, Torres C. Prevalence and diversity of integrons and associated resistance genes in Escherichia coli isolates from poultry meat in Tunisia. Foodborne Pathog Dis. 2009;6:1067–1073. doi: 10.1089/fpd.2009.0284. [DOI] [PubMed] [Google Scholar]
  • 12.Svennerholm AM, Wiklund G. Rapid GM1-enzyme-linked immunosorbent assay with visual reading for identification of Escherichia coli heat-labile enterotoxin. J Clin Microbiol. 1983;17:596–600. doi: 10.1128/jcm.17.4.596-600.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Svennerholm AM, Wikström M, Lindblad M, Holmgren J. Monoclonal antibodies against Escherichia coli heat-stable toxin (STa) and their use in a diagnostic ST ganglioside GM1-enzyme-linked immunosorbent assay. J Clin Microbiol. 1986;24:585–590. doi: 10.1128/jcm.24.4.585-590.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Svennerholm AM, Tobias J. Vaccines against enterotoxigenic Escherichia coli. Expert Rev Vaccines. 2008;7:795–804. doi: 10.1586/14760584.7.6.795. [DOI] [PubMed] [Google Scholar]
  • 15.Valvatne H, Sommerfelt H, Gaastra W, Bhan MK, Grewal HM. Identification and characterization of CS20, a new putative colonization factor of enterotoxigenic Escherichia coli. Infect Immun. 1996;64:2635–2642. doi: 10.1128/iai.64.7.2635-2642.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Valvatne H, Steinsland H, Grewal HM, Mølbak K, Vuust J, Sommerfelt H. Identification and molecular characterization of the gene encoding coli surface antigen 20 of enterotoxigenic Escherichia coli. FEMS Microbiol Lett. 2004;239:131–138. doi: 10.1016/j.femsle.2004.08.028. [DOI] [PubMed] [Google Scholar]
  • 17.Viboud GI, Binsztein N, Svennerholm AM. Characterization of monoclonal antibodies against putative colonization factors of enterotoxigenic Escherichia coli and their use in an epidemiological study. J Clin Microbiol. 1993;31:558–564. doi: 10.1128/jcm.31.3.558-564.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Walker RI, Steele D, Aguado T Ad Hoc ETEC Technical Expert Committee. Analysis of strategies to successfully vaccinate infants in developing countries against enterotoxigenic E. coli (ETEC) disease. Vaccine. 2007;25:2545–2566. doi: 10.1016/j.vaccine.2006.12.028. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supp Fig S1

RESOURCES